Resolutions of the 31st Annual General Meeting of DocMorris AG of 2 May 2024
in Zurich

DocMorris AG / Key word(s): AGMEGM
Resolutions of the 31st Annual General Meeting of DocMorris AG of 2 May 2024
in Zurich

02.05.2024 / 18:45 CET/CEST

---------------------------------------------------------------------------

Frauenfeld, 2 May 2024

Press release

Resolutions of the 31st Annual General Meeting of DocMorris AG of 2 May 2024
in Zurich

  * The shareholders approved the annual report and consolidated and
    statutory financial statements for 2023 and the Board of Directors'
    proposal for the appropriation of the balance sheet result 2023.

  * Discharge was granted to all members of the Board of Directors and the
    Executive Board.

  * All members of the Board of Directors and the Nomination and
    Compensation Committee were confirmed for a further term of office until
    the next Annual General Meeting.

  * Amendments to the Articles of Association: The amendments to the
    provisions in line with the new company law and the main proposal to
    adjust the threshold for placing an item on the agenda were approved.
    The additions to the article in the Articles of Association on
    conditional share capital for financing, acquisitions and other purposes
    were also approved.

  * Buis Bürgi AG as independent proxy and Ernst & Young AG as auditors were
    re-elected.

* The Annual General Meeting approved the Sustainability Report 2023.

  * The shareholders also approved the compensation for the Board of
    Directors and the Executive Board. Mainly based on the recommendations
    of a proxy advisor who had already criticised the transparency of the
    compensation system prior to the Annual General Meeting, the 2023
    Compensation Report was rejected in a consultative vote. DocMorris will
    examine this criticism in detail and seek dialogue on this topic with
    larger shareholders in order to present a Compensation Report next year
    that is widely accepted.

Investors and analyst contact
Dr. Daniel Grigat, Head of Investor Relations & Sustainability
Email: ir@docmorris.com, phone: +41 52 560 58 10

Media contact
Torben Bonnke, Director Communications
Email: media@docmorris.com, phone: +49 171 864 888 1


Agenda

     20 August 2024     2024 Half-year results (conference call/webcast)
     15 October 2024    Q3/2024 Trading update

DocMorris

The Swiss-based DocMorris AG is a leading company in the fields of online
pharmacy, marketplace and professional healthcare with strong brands in
Germany and other European countries. Deliveries are mainly from the highly
automated logistics centre in Heerlen, the Netherlands, with a capacity of
over 27 million parcels per year. In Spain and France, the company operates
the leading marketplace for health and personal care products in Southern
Europe. With its business model, DocMorris offers its patients, customers
and partners a broad range of products and services. In doing so, DocMorris
is pursuing its vision of creating a digital health ecosystem for everyone
to manage their health in one click. The company was renamed from Zur Rose
Group AG to DocMorris AG in May 2023 after the Swiss business was sold to
Migros/Medbase. Excluding the Swiss business, about 1,600 employees in
Germany, the Netherlands, Spain, France and Switzerland generated an
external revenue of CHF 1,038 million serving over 9 million active
customers in 2023. The shares of DocMorris AG are listed on the SIX Swiss
Exchange (securities number 4261528, ISIN CH0042615283, ticker DOCM). For
further information, please visit corporate.docmorris.com.


---------------------------------------------------------------------------

End of Media Release

---------------------------------------------------------------------------

   Language:       English
   Company:        DocMorris AG
                   Walzmühlestrasse 49
                   8500 Frauenfeld
                   Switzerland
   ISIN:           CH0042615283
   Listed:         SIX Swiss Exchange
   EQS News ID:    1894643

End of News EQS News Service
---------------------------------------------------------------------------

1894643 02.05.2024 CET/CEST